Skip to content

Obesity Tech

Health First

  • Your Health Checker
    • Early Childhood Obesity Calculator
    • Gut Health Score Calculator
    • BMI Calculator Women
    • Obesity Risk Assessment Tool
    • BMI Calculator
    • Waist-to-Hip Ratio Calculator
    • Calorie Deficit Calculator
    • Stroke Risk Checker
    • Your Body, Your Healthy Weight Range
    • Mindful Eating Score Calculator 
    • Sedentary Behavior Impact Calculator
    • What Is Body Roundness Index (BRI)?
    • Visceral Fat Calculator
  • Research Insights
  • Advisory
  • Tech
  • Story
    • 10 Ultra-Processed Foods to Avoid for Obesity Prevention
    • 10 Superfoods That Help You Lose Belly Fat Naturally
  • Metabolic Age Calculator
  • All-in-One Obesity and Metabolic Health Calculator

Author: ObesityTechTeam

  • Home
  • ObesityTechTeam
GLP-1 Weight Loss Drugs: A Medical Breakthrough or a New Health Challenge?
3 min 0
  • Research Insights

GLP-1 Weight Loss Drugs: A Medical Breakthrough or a New Health Challenge?

  • ObesityTechTeam
  • November 17, 2026
The global fight against obesity is entering a new era. GLP-1 weight-loss medications, including semaglutide…
Read More
FDA Warns Ozempic, Wegovy and Mounjaro Users About Rare “Eye Stroke” Risk: What Is NAION?
3 min 0
  • Research Insights

FDA Warns Ozempic, Wegovy and Mounjaro Users About Rare “Eye Stroke” Risk: What Is NAION?

  • ObesityTechTeam
  • November 12, 2026
The US Food and Drug Administration (FDA) has ordered manufacturers of GLP-1 medications to update…
Read More
UK Obesity Rate: A Persistent Public Health Challenge
4 min 0
  • Research Insights

UK Obesity Rate: A Persistent Public Health Challenge

  • ObesityTechTeam
  • September 14, 2026
Obesity remains one of the United Kingdom’s most persistent public health challenges. In England, the…
Read More
Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained
3 min 0
  • Research Insights

Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained

  • ObesityTechTeam
  • August 23, 2026
Semaglutide is a prescription medicine that belongs to the GLP-1 receptor agonist class. It has…
Read More
BMI 30 in Men Explained: Is It Obesity, How Serious Is It and What Happens Next?
4 min 0
  • Advisory

BMI 30 in Men Explained: Is It Obesity, How Serious Is It and What Happens Next?

  • ObesityTechTeam
  • August 20, 2026
A BMI of 30 in a male is an important health marker. Under widely used…
Read More
Foods With the Highest Trans Fats: Common Sources to Watch
3 min 0
  • Advisory

Foods With the Highest Trans Fats: Common Sources to Watch

  • ObesityTechTeam
  • August 17, 2026
The foods most likely to contain high amounts of industrial trans fat are typically products…
Read More
Top Obesity Biotech Companies in 2026: Beyond Novo Nordisk and Eli Lilly
4 min 0
  • Research Insights

Top Obesity Biotech Companies in 2026: Beyond Novo Nordisk and Eli Lilly

  • ObesityTechTeam
  • August 16, 2026
The obesity drug race is no longer limited to Novo Nordisk and Eli Lilly. A…
Read More

Posts pagination

1 2 … 4 Next

Recent Posts

  • GLP-1 Weight Loss Drugs: A Medical Breakthrough or a New Health Challenge?
  • FDA Warns Ozempic, Wegovy and Mounjaro Users About Rare “Eye Stroke” Risk: What Is NAION?
  • AI Discovers BRP, a Potential “Natural Ozempic” Alternative for Weight Loss
  • BMI Chart for Women: Healthy BMI Range by Age, Height and Weight
  • UK Obesity Rate: A Persistent Public Health Challenge

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • January 2026
  • September 2025
  • August 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Advisory
  • Research Insights
  • Story
  • Tech

Health Calculators

  • Your Health Checker
  • BMI Calculator
  • Contributor’s
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2026 Obesity Tech Theme: Clear Blog By Adore Themes.